PriceSensitive

PainChek (ASX:PCK) prepares for capital raise

The Market Online Deal Room
ASX:PCK      MCAP $45.19M
07 August 2020 10:00 (AEDT)
PainChek (ASX:PCK) - CEO, Philip Daffas

Source: PainChek

Healthtech company PainChek (PCK) has announced it is gearing up for a capital raise after placing its shares in a trading halt.

The company, who created an app which diagnoses pain, will release full details of the raise in the coming days, with the trading halt to be lifted on August 11.

PainChek ended the June quarter with $5.87 million cash in the bank, after burning through $754,000 in operating costs.

It estimates its cash outflow will total $1.78 million over the next quarter as it ramps up research and development, advertising and marketing, and product manufacturing.

Painchek also recorded some positive growth during the June quarter, increasing the number of beds under licence by 24 per cent quarter-on-quarter.

In total the company now has 61,571 aged care beds signed on to use its technology, representing a 481 per cent increases year-on-year.

Painchek said moving forward, it would be focused on entering the home care market, expanding into the U.S. and into other international markets.

Before today’s trading halt, shares in PainChek were trading for 13 cents per share on August 6.

Related News